| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Blood Platelets | 19 | 2020 | 340 | 3.270 |
Why?
|
| Actins | 5 | 2020 | 350 | 2.050 |
Why?
|
| Phosphatidylserines | 11 | 2020 | 50 | 1.870 |
Why?
|
| Antiphospholipid Syndrome | 5 | 2024 | 27 | 1.670 |
Why?
|
| Phagocytosis | 8 | 2024 | 192 | 1.500 |
Why?
|
| Antigens, Surface | 7 | 2017 | 119 | 1.320 |
Why?
|
| beta 2-Glycoprotein I | 5 | 2024 | 11 | 1.140 |
Why?
|
| Platelet Activation | 8 | 2016 | 71 | 1.120 |
Why?
|
| Cardiolipins | 4 | 2024 | 18 | 1.100 |
Why?
|
| Endothelium, Vascular | 6 | 2025 | 522 | 1.060 |
Why?
|
| Viper Venoms | 1 | 2025 | 3 | 0.980 |
Why?
|
| Elapid Venoms | 1 | 2025 | 10 | 0.980 |
Why?
|
| Snake Bites | 1 | 2025 | 14 | 0.970 |
Why?
|
| Microfilament Proteins | 2 | 2018 | 289 | 0.960 |
Why?
|
| Platelet Aggregation | 8 | 2019 | 124 | 0.950 |
Why?
|
| Cell-Derived Microparticles | 6 | 2019 | 30 | 0.950 |
Why?
|
| Thrombosis | 10 | 2023 | 540 | 0.930 |
Why?
|
| Cofilin 1 | 3 | 2020 | 14 | 0.930 |
Why?
|
| Antibodies, Antiphospholipid | 4 | 2024 | 20 | 0.920 |
Why?
|
| Platelet Adhesiveness | 3 | 2018 | 41 | 0.910 |
Why?
|
| Blood Coagulation | 7 | 2025 | 130 | 0.890 |
Why?
|
| Milk Proteins | 7 | 2017 | 92 | 0.880 |
Why?
|
| Anemia, Hemolytic, Autoimmune | 1 | 2023 | 29 | 0.840 |
Why?
|
| Blood Coagulation Disorders | 5 | 2025 | 106 | 0.740 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2023 | 147 | 0.730 |
Why?
|
| Sulfoglycosphingolipids | 5 | 2011 | 8 | 0.710 |
Why?
|
| Endothelial Cells | 3 | 2025 | 544 | 0.710 |
Why?
|
| Erythrocytes | 6 | 2023 | 237 | 0.700 |
Why?
|
| Clot Retraction | 1 | 2018 | 6 | 0.600 |
Why?
|
| Focal Adhesions | 1 | 2018 | 14 | 0.600 |
Why?
|
| Thrombocytopenia | 2 | 2013 | 236 | 0.590 |
Why?
|
| Mice | 25 | 2025 | 18963 | 0.580 |
Why?
|
| Macrophages | 3 | 2024 | 703 | 0.580 |
Why?
|
| Immunoglobulin Variable Region | 3 | 2008 | 52 | 0.560 |
Why?
|
| rho-Associated Kinases | 2 | 2017 | 57 | 0.540 |
Why?
|
| Dasatinib | 1 | 2017 | 49 | 0.530 |
Why?
|
| Thrombin | 4 | 2013 | 62 | 0.500 |
Why?
|
| Neutrophils | 2 | 2010 | 401 | 0.500 |
Why?
|
| Prothrombin | 2 | 2007 | 26 | 0.490 |
Why?
|
| Granuloma, Giant Cell | 1 | 2015 | 12 | 0.490 |
Why?
|
| Bone Marrow Diseases | 1 | 2015 | 41 | 0.470 |
Why?
|
| Animals | 28 | 2025 | 36443 | 0.470 |
Why?
|
| Autoantibodies | 5 | 2023 | 466 | 0.470 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2015 | 90 | 0.460 |
Why?
|
| Blood Preservation | 2 | 2020 | 32 | 0.460 |
Why?
|
| Annexin A5 | 4 | 2016 | 16 | 0.450 |
Why?
|
| Multiprotein Complexes | 1 | 2015 | 218 | 0.430 |
Why?
|
| Platelet Factor 4 | 1 | 2013 | 23 | 0.420 |
Why?
|
| Platelet Transfusion | 1 | 2013 | 54 | 0.410 |
Why?
|
| Erythrocytes, Abnormal | 3 | 2011 | 19 | 0.410 |
Why?
|
| Cytoplasmic Vesicles | 2 | 2010 | 9 | 0.400 |
Why?
|
| Mice, Knockout | 11 | 2025 | 3994 | 0.400 |
Why?
|
| Lupus Erythematosus, Systemic | 3 | 2004 | 213 | 0.400 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2013 | 92 | 0.390 |
Why?
|
| Collagen | 1 | 2013 | 327 | 0.380 |
Why?
|
| Gout | 1 | 2015 | 167 | 0.380 |
Why?
|
| Brain Injuries, Traumatic | 3 | 2025 | 300 | 0.380 |
Why?
|
| Hemostasis | 3 | 2008 | 70 | 0.380 |
Why?
|
| Heparin | 1 | 2013 | 225 | 0.370 |
Why?
|
| Antibodies | 1 | 2013 | 382 | 0.370 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 5 | 2025 | 866 | 0.370 |
Why?
|
| Macrophage Activation | 2 | 2008 | 68 | 0.370 |
Why?
|
| Thrombocythemia, Essential | 2 | 2023 | 30 | 0.370 |
Why?
|
| Polycythemia Vera | 2 | 2023 | 39 | 0.360 |
Why?
|
| Peptide Fragments | 3 | 2015 | 833 | 0.350 |
Why?
|
| Erythrocyte Inclusions | 1 | 2010 | 2 | 0.340 |
Why?
|
| Ganciclovir | 1 | 2010 | 104 | 0.330 |
Why?
|
| Humans | 45 | 2025 | 133748 | 0.330 |
Why?
|
| Mice, Inbred C57BL | 11 | 2025 | 4851 | 0.310 |
Why?
|
| Bacteremia | 1 | 2013 | 426 | 0.310 |
Why?
|
| Cellular Senescence | 1 | 2010 | 201 | 0.300 |
Why?
|
| Anemia, Sickle Cell | 3 | 2011 | 342 | 0.300 |
Why?
|
| Signal Transduction | 4 | 2023 | 4912 | 0.290 |
Why?
|
| Apoptosis | 7 | 2025 | 1937 | 0.290 |
Why?
|
| Leukocytes | 2 | 2006 | 223 | 0.280 |
Why?
|
| Fluorescein-5-isothiocyanate | 3 | 2017 | 31 | 0.280 |
Why?
|
| Peptide Library | 2 | 2004 | 61 | 0.270 |
Why?
|
| Citrobacter freundii | 1 | 2006 | 3 | 0.270 |
Why?
|
| Cell Membrane | 2 | 2008 | 487 | 0.260 |
Why?
|
| Carrier Proteins | 1 | 2012 | 1069 | 0.260 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2006 | 59 | 0.260 |
Why?
|
| Blood Coagulation Factors | 1 | 2006 | 35 | 0.240 |
Why?
|
| von Willebrand Factor | 2 | 2018 | 202 | 0.230 |
Why?
|
| India | 1 | 2025 | 239 | 0.230 |
Why?
|
| Inclusion Bodies | 1 | 2005 | 48 | 0.230 |
Why?
|
| Antibody Specificity | 2 | 2004 | 206 | 0.230 |
Why?
|
| Plasma Cells | 1 | 2005 | 57 | 0.230 |
Why?
|
| Rabbits | 1 | 2025 | 729 | 0.220 |
Why?
|
| Kringles | 1 | 2004 | 3 | 0.220 |
Why?
|
| Antiviral Agents | 1 | 2010 | 824 | 0.220 |
Why?
|
| Coombs Test | 1 | 2023 | 6 | 0.210 |
Why?
|
| Heart Transplantation | 2 | 2010 | 895 | 0.210 |
Why?
|
| Cells, Cultured | 5 | 2025 | 3177 | 0.210 |
Why?
|
| Glycoproteins | 2 | 2003 | 379 | 0.210 |
Why?
|
| Hemolysis | 1 | 2023 | 113 | 0.210 |
Why?
|
| Mitochondria | 5 | 2019 | 744 | 0.200 |
Why?
|
| Protein Binding | 6 | 2015 | 1847 | 0.200 |
Why?
|
| Cell Adhesion | 4 | 2025 | 362 | 0.200 |
Why?
|
| Immunoglobulin A | 1 | 2023 | 219 | 0.200 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 2 | 2016 | 64 | 0.200 |
Why?
|
| Multiple Myeloma | 1 | 2005 | 199 | 0.190 |
Why?
|
| Host Cell Factor C1 | 1 | 2022 | 11 | 0.190 |
Why?
|
| Phospholipids | 1 | 2002 | 113 | 0.190 |
Why?
|
| Membrane Proteins | 2 | 2008 | 1605 | 0.190 |
Why?
|
| Sepsis | 1 | 2006 | 519 | 0.190 |
Why?
|
| Nitrophenols | 2 | 2020 | 16 | 0.190 |
Why?
|
| Homocystinuria | 1 | 2022 | 27 | 0.190 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2022 | 45 | 0.180 |
Why?
|
| Male | 16 | 2025 | 65884 | 0.180 |
Why?
|
| Altitude | 1 | 2021 | 23 | 0.180 |
Why?
|
| Oxidoreductases | 1 | 2022 | 103 | 0.180 |
Why?
|
| Biphenyl Compounds | 2 | 2020 | 62 | 0.180 |
Why?
|
| Antibodies, Monoclonal | 3 | 2025 | 1069 | 0.180 |
Why?
|
| Ribosomes | 1 | 2022 | 140 | 0.180 |
Why?
|
| Brain Injuries | 2 | 2018 | 722 | 0.180 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 2022 | 115 | 0.170 |
Why?
|
| Erythropoietin | 1 | 2021 | 110 | 0.170 |
Why?
|
| Immunoglobulin G | 1 | 2023 | 824 | 0.170 |
Why?
|
| Fibrinolytic Agents | 1 | 2002 | 203 | 0.160 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2017 | 1735 | 0.160 |
Why?
|
| Cell Line | 5 | 2015 | 2844 | 0.160 |
Why?
|
| Piperazines | 2 | 2020 | 257 | 0.160 |
Why?
|
| Aryldialkylphosphatase | 1 | 2019 | 9 | 0.160 |
Why?
|
| Boron Compounds | 2 | 2010 | 34 | 0.160 |
Why?
|
| Flow Cytometry | 4 | 2010 | 836 | 0.160 |
Why?
|
| Sulfonamides | 2 | 2020 | 286 | 0.160 |
Why?
|
| Bone Marrow | 2 | 2015 | 335 | 0.160 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 897 | 0.150 |
Why?
|
| Cytoskeleton | 1 | 2020 | 175 | 0.150 |
Why?
|
| Protein Interaction Maps | 1 | 2018 | 90 | 0.140 |
Why?
|
| Microvessels | 1 | 2018 | 63 | 0.140 |
Why?
|
| Gene Deletion | 2 | 2018 | 809 | 0.140 |
Why?
|
| Cell Adhesion Molecules | 2 | 2025 | 254 | 0.140 |
Why?
|
| Calcium-Binding Proteins | 2 | 2025 | 336 | 0.140 |
Why?
|
| rhoA GTP-Binding Protein | 1 | 2017 | 47 | 0.130 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2019 | 284 | 0.130 |
Why?
|
| Capillary Permeability | 1 | 2017 | 77 | 0.130 |
Why?
|
| Talin | 1 | 2016 | 11 | 0.130 |
Why?
|
| Phosphorylation | 3 | 2017 | 1707 | 0.130 |
Why?
|
| Permeability | 1 | 2017 | 131 | 0.130 |
Why?
|
| Hypercholesterolemia | 1 | 2019 | 236 | 0.130 |
Why?
|
| Repressor Proteins | 1 | 2022 | 869 | 0.130 |
Why?
|
| Gene Expression | 2 | 2023 | 1616 | 0.130 |
Why?
|
| Disease Models, Animal | 6 | 2025 | 4796 | 0.130 |
Why?
|
| Platelet Function Tests | 3 | 2019 | 40 | 0.130 |
Why?
|
| Mitochondrial Membranes | 1 | 2016 | 31 | 0.130 |
Why?
|
| Reactive Oxygen Species | 2 | 2019 | 526 | 0.130 |
Why?
|
| Cyclooxygenase 2 | 1 | 2016 | 143 | 0.120 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2016 | 434 | 0.120 |
Why?
|
| Catalase | 1 | 2015 | 69 | 0.120 |
Why?
|
| Lipopolysaccharides | 2 | 2015 | 320 | 0.120 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2015 | 105 | 0.110 |
Why?
|
| Uric Acid | 1 | 2015 | 110 | 0.110 |
Why?
|
| P-Selectin | 2 | 2005 | 80 | 0.110 |
Why?
|
| Endotoxemia | 1 | 2015 | 56 | 0.110 |
Why?
|
| Immunoglobulin Fragments | 2 | 2004 | 13 | 0.110 |
Why?
|
| Lim Kinases | 1 | 2013 | 8 | 0.110 |
Why?
|
| Amides | 1 | 2013 | 87 | 0.100 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2014 | 126 | 0.100 |
Why?
|
| Hypoxia | 1 | 2015 | 268 | 0.100 |
Why?
|
| Cross Reactions | 1 | 2013 | 195 | 0.100 |
Why?
|
| Specimen Handling | 1 | 2013 | 148 | 0.100 |
Why?
|
| Epitopes | 2 | 2004 | 446 | 0.100 |
Why?
|
| Pyridines | 1 | 2013 | 248 | 0.100 |
Why?
|
| Liposomes | 2 | 2003 | 207 | 0.100 |
Why?
|
| Binding Sites | 2 | 2007 | 1378 | 0.090 |
Why?
|
| Protein Subunits | 2 | 2022 | 174 | 0.090 |
Why?
|
| Biopsy | 1 | 2015 | 1302 | 0.090 |
Why?
|
| Endocytosis | 1 | 2012 | 133 | 0.090 |
Why?
|
| Transforming Growth Factor beta | 1 | 2014 | 484 | 0.090 |
Why?
|
| Erythrocyte Membrane | 1 | 2011 | 24 | 0.090 |
Why?
|
| Atherosclerosis | 1 | 2019 | 999 | 0.090 |
Why?
|
| Adult | 3 | 2025 | 31892 | 0.090 |
Why?
|
| Cyclophilins | 1 | 2010 | 20 | 0.090 |
Why?
|
| Cytochromes c | 1 | 2010 | 52 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2012 | 262 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2012 | 351 | 0.080 |
Why?
|
| In Vitro Techniques | 3 | 2014 | 992 | 0.080 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 381 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2012 | 508 | 0.080 |
Why?
|
| Phenanthrenes | 1 | 2008 | 5 | 0.080 |
Why?
|
| Receptors, Androgen | 1 | 2012 | 433 | 0.080 |
Why?
|
| Maleimides | 1 | 2008 | 11 | 0.080 |
Why?
|
| Fluorescent Dyes | 1 | 2010 | 270 | 0.080 |
Why?
|
| Cytomegalovirus | 1 | 2010 | 270 | 0.080 |
Why?
|
| Ethylmaleimide | 1 | 2008 | 13 | 0.080 |
Why?
|
| Calcimycin | 1 | 2008 | 24 | 0.080 |
Why?
|
| Edetic Acid | 1 | 2008 | 25 | 0.070 |
Why?
|
| Calcium Chloride | 1 | 2008 | 23 | 0.070 |
Why?
|
| Cattle | 2 | 2007 | 587 | 0.070 |
Why?
|
| Cerebroside-Sulfatase | 1 | 2008 | 9 | 0.070 |
Why?
|
| Hemorheology | 1 | 2008 | 27 | 0.070 |
Why?
|
| Erythroid Cells | 1 | 2008 | 24 | 0.070 |
Why?
|
| Erythropoiesis | 1 | 2008 | 43 | 0.070 |
Why?
|
| Cytomegalovirus Infections | 1 | 2010 | 229 | 0.070 |
Why?
|
| Spleen | 1 | 2008 | 292 | 0.070 |
Why?
|
| Female | 4 | 2025 | 71644 | 0.070 |
Why?
|
| Aztreonam | 1 | 2006 | 4 | 0.070 |
Why?
|
| Binding, Competitive | 1 | 2007 | 194 | 0.070 |
Why?
|
| HL-60 Cells | 1 | 2006 | 34 | 0.060 |
Why?
|
| Mitochondrial Proteins | 1 | 2008 | 243 | 0.060 |
Why?
|
| Fibrinogen | 1 | 2007 | 163 | 0.060 |
Why?
|
| Immunosuppressive Agents | 1 | 2010 | 694 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2013 | 3654 | 0.060 |
Why?
|
| Thrombomodulin | 1 | 2025 | 23 | 0.060 |
Why?
|
| Hyalin | 1 | 2005 | 6 | 0.060 |
Why?
|
| Membrane Fusion | 1 | 2005 | 37 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2008 | 278 | 0.060 |
Why?
|
| Thromboplastin | 1 | 2005 | 19 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 2015 | 2658 | 0.060 |
Why?
|
| Thromboembolism | 1 | 2005 | 90 | 0.060 |
Why?
|
| Extracellular Vesicles | 1 | 2025 | 55 | 0.060 |
Why?
|
| Autophagy | 1 | 2008 | 424 | 0.060 |
Why?
|
| Membrane Microdomains | 1 | 2005 | 63 | 0.060 |
Why?
|
| Bacteriophage M13 | 1 | 2004 | 18 | 0.060 |
Why?
|
| Immunoglobulin Light Chains | 1 | 2004 | 25 | 0.060 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2004 | 50 | 0.050 |
Why?
|
| Binding Sites, Antibody | 1 | 2004 | 100 | 0.050 |
Why?
|
| HIV Envelope Protein gp120 | 1 | 2004 | 24 | 0.050 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2003 | 4 | 0.050 |
Why?
|
| Immunosorbent Techniques | 1 | 2003 | 27 | 0.050 |
Why?
|
| Endoplasmic Reticulum | 1 | 2005 | 229 | 0.050 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2005 | 216 | 0.050 |
Why?
|
| Macromolecular Substances | 1 | 2003 | 185 | 0.050 |
Why?
|
| STAT Transcription Factors | 1 | 2023 | 25 | 0.050 |
Why?
|
| Janus Kinases | 1 | 2023 | 33 | 0.050 |
Why?
|
| Prostatic Neoplasms | 1 | 2012 | 1623 | 0.050 |
Why?
|
| Amino Acid Sequence | 2 | 2004 | 2789 | 0.050 |
Why?
|
| Protein Structure, Quaternary | 1 | 2002 | 102 | 0.050 |
Why?
|
| Monocytes | 1 | 2005 | 360 | 0.050 |
Why?
|
| Brain | 1 | 2015 | 3226 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2002 | 388 | 0.050 |
Why?
|
| Reticulocytes | 2 | 2015 | 44 | 0.050 |
Why?
|
| Sjogren's Syndrome | 1 | 2003 | 98 | 0.050 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2023 | 119 | 0.050 |
Why?
|
| Pregnancy | 1 | 2015 | 7545 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 2004 | 3971 | 0.050 |
Why?
|
| Organelle Biogenesis | 1 | 2022 | 19 | 0.050 |
Why?
|
| Vitamin B 12 | 1 | 2022 | 63 | 0.050 |
Why?
|
| Ribosomal Proteins | 1 | 2022 | 75 | 0.050 |
Why?
|
| Calcium | 1 | 2006 | 1148 | 0.040 |
Why?
|
| Anticoagulants | 2 | 2005 | 604 | 0.040 |
Why?
|
| Drug Design | 1 | 2002 | 168 | 0.040 |
Why?
|
| Time Factors | 2 | 2008 | 6583 | 0.040 |
Why?
|
| Heterozygote | 1 | 2002 | 720 | 0.040 |
Why?
|
| HIV-1 | 1 | 2004 | 487 | 0.040 |
Why?
|
| Embryo, Mammalian | 1 | 2022 | 466 | 0.040 |
Why?
|
| Leukocyte Count | 1 | 2020 | 259 | 0.040 |
Why?
|
| Stroke | 1 | 2008 | 1074 | 0.040 |
Why?
|
| Purinergic P2Y Receptor Antagonists | 1 | 2019 | 47 | 0.040 |
Why?
|
| Receptors, LDL | 1 | 2019 | 102 | 0.040 |
Why?
|
| Protein Biosynthesis | 1 | 2022 | 676 | 0.040 |
Why?
|
| Mutation | 2 | 2022 | 6295 | 0.040 |
Why?
|
| Survival | 1 | 2017 | 19 | 0.040 |
Why?
|
| Inflammation | 1 | 2006 | 1591 | 0.040 |
Why?
|
| Trauma Severity Indices | 1 | 2017 | 86 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2022 | 1048 | 0.030 |
Why?
|
| Homeostasis | 1 | 2021 | 747 | 0.030 |
Why?
|
| Cyclooxygenase 1 | 1 | 2016 | 43 | 0.030 |
Why?
|
| Heart-Assist Devices | 1 | 2005 | 1094 | 0.030 |
Why?
|
| Tyrosine | 2 | 2008 | 159 | 0.030 |
Why?
|
| Acute Coronary Syndrome | 1 | 2019 | 238 | 0.030 |
Why?
|
| Polycythemia | 1 | 2015 | 44 | 0.030 |
Why?
|
| Fibrin | 1 | 2015 | 65 | 0.030 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2015 | 67 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2006 | 2569 | 0.030 |
Why?
|
| Smad Proteins, Receptor-Regulated | 1 | 2014 | 2 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2015 | 109 | 0.030 |
Why?
|
| Feedback, Physiological | 1 | 2014 | 72 | 0.030 |
Why?
|
| Protein Phosphatase 2C | 1 | 2014 | 60 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 259 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 197 | 0.030 |
Why?
|
| Disease Progression | 2 | 2012 | 2240 | 0.020 |
Why?
|
| Castration | 1 | 2012 | 33 | 0.020 |
Why?
|
| Chromones | 1 | 2012 | 26 | 0.020 |
Why?
|
| Membrane Glycoproteins | 2 | 2005 | 432 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2016 | 1763 | 0.020 |
Why?
|
| Androstadienes | 1 | 2012 | 52 | 0.020 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2012 | 94 | 0.020 |
Why?
|
| Morpholines | 1 | 2012 | 64 | 0.020 |
Why?
|
| Models, Theoretical | 1 | 2014 | 398 | 0.020 |
Why?
|
| Up-Regulation | 1 | 2014 | 907 | 0.020 |
Why?
|
| HIV Infections | 1 | 2004 | 2072 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2015 | 1439 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2014 | 592 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2015 | 1044 | 0.020 |
Why?
|
| Sulfotransferases | 1 | 2011 | 28 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 429 | 0.020 |
Why?
|
| Mesenteric Vascular Occlusion | 1 | 2011 | 28 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2014 | 708 | 0.020 |
Why?
|
| Single-Chain Antibodies | 1 | 2011 | 45 | 0.020 |
Why?
|
| Protein Engineering | 1 | 2011 | 74 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2006 | 13007 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2014 | 616 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 3743 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2016 | 2902 | 0.020 |
Why?
|
| Computational Biology | 1 | 2014 | 887 | 0.020 |
Why?
|
| Carbonyl Cyanide p-Trifluoromethoxyphenylhydrazone | 1 | 2008 | 4 | 0.020 |
Why?
|
| Middle Aged | 2 | 2005 | 29314 | 0.020 |
Why?
|
| Aged | 1 | 2006 | 21687 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 950 | 0.020 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 2008 | 65 | 0.020 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2007 | 17 | 0.020 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 177 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2012 | 1758 | 0.020 |
Why?
|
| Cell Survival | 1 | 2008 | 889 | 0.020 |
Why?
|
| Factor VIIa | 1 | 2005 | 24 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2012 | 1620 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 2004 | 25 | 0.010 |
Why?
|
| Solubility | 1 | 2005 | 145 | 0.010 |
Why?
|
| Leukocyte Common Antigens | 1 | 2005 | 93 | 0.010 |
Why?
|
| Adenosine Diphosphate | 1 | 2004 | 55 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2012 | 3758 | 0.010 |
Why?
|
| Acute Disease | 1 | 2008 | 1191 | 0.010 |
Why?
|
| Fatal Outcome | 1 | 2005 | 376 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2004 | 318 | 0.010 |
Why?
|
| Peptides | 1 | 2008 | 860 | 0.010 |
Why?
|
| Dose-Response Relationship, Immunologic | 1 | 2004 | 109 | 0.010 |
Why?
|
| Waiting Lists | 1 | 2005 | 244 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 911 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2008 | 1153 | 0.010 |
Why?
|
| Phenotype | 1 | 2012 | 4552 | 0.010 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2004 | 357 | 0.010 |
Why?
|
| Cholesterol | 1 | 2005 | 574 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2005 | 3098 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2005 | 3708 | 0.010 |
Why?
|